Literature DB >> 10471130

In vivo conversion of linoleic acid to arachidonic acid in human adults.

N Salem1, R Pawlosky, B Wegher, J Hibbeln.   

Abstract

Human adults are shown to be capable of conversion of linoleic acid (LA, 18:2 n-6) to arachidonic acid (AA, 20:4 n-6) in vivo. It is confirmed that they can also convert alpha-linolenic acid (LNA, 18:3 n-3) to eicosapentaenoic acid (EPA, 20:5 n-3) and to docosahexaenoic acid (DHA, 22:6 n-3) in vivo. The time course and the maximal response for these processes during the first week after a single dose of the 18-carbon precursor is described. A stable-isotope method in which the protons of the C17 and C18 carbons are substituted with deuterium atoms is used in order to provide for a safe method for the study of human metabolism. High sensitivity and selectivity of detection is assured with negative ion, gas chromatography/mass spectrometry analysis. It is clear that human adults on an ad lib diet carry out EFA metabolism in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471130     DOI: 10.1016/s0952-3278(99)80021-0

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  30 in total

Review 1.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

Review 2.  Essential fats: how do they affect growth and development of infants and young children in developing countries? A literature review.

Authors:  Sandra L Huffman; Rajwinder K Harika; Ans Eilander; Saskia J M Osendarp
Journal:  Matern Child Nutr       Date:  2011-10       Impact factor: 3.092

3.  Complete assessment of whole-body n-3 and n-6 PUFA synthesis-secretion kinetics and DHA turnover in a rodent model.

Authors:  Adam H Metherel; R J Scott Lacombe; Raphaël Chouinard-Watkins; Kathryn E Hopperton; Richard P Bazinet
Journal:  J Lipid Res       Date:  2017-12-11       Impact factor: 5.922

4.  Lipid remodeling in mouse liver and plasma resulting from delta6 fatty acid desaturase inhibition.

Authors:  K L Duffin; M G Obukowicz; W J Salsgiver; D J Welsch; C Shieh; A Raz; P Needleman
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

Review 5.  Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders.

Authors:  Alexandra J Richardson
Journal:  Lipids       Date:  2004-12       Impact factor: 1.880

6.  Distribution of omega-6 and omega-3 polyunsaturated fatty acids in the whole rat body and 25 compartments.

Authors:  N M Salem; Y H Lin; T Moriguchi; S Y Lim; N Salem; J R Hibbeln
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-06-14       Impact factor: 4.006

7.  Dose effect of alpha-linolenic acid on PUFA conversion, bioavailability, and storage in the hamster.

Authors:  Anne Morise; Nicole Combe; Carole Boué; Philippe Legrand; Daniel Catheline; Bernadette Delplanque; Evelyne Fénart; Pierre Weill; Dominique Hermier
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

8.  Bipolar disorder moderates associations between linoleic acid and markers of inflammation.

Authors:  Ya-Wen Chang; Shervin Assari; Alan R Prossin; Laura Stertz; Melvin G McInnis; Simon J Evans
Journal:  J Psychiatr Res       Date:  2016-10-27       Impact factor: 4.791

Review 9.  omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.

Authors:  Monika K Duda; Karen M O'Shea; William C Stanley
Journal:  Cardiovasc Res       Date:  2009-05-27       Impact factor: 10.787

Review 10.  Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.

Authors:  Jan Philipp Schuchardt; Michael Huss; Manuela Stauss-Grabo; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2009-08-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.